APH-2501

N/A

Report date: 2025/08/22 11:40:08

NME

Base Information

Drug NameAPH-2501

Drug Alias NameAPH-2501

ClassificationOther

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies +[1] N/A

China Registration ClassN/A

Develop Information

Active Companies +[1] N/A

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A